Business Description
Argent BioPharma Limited is an Australian-based drug development company founded in 2014, focused on creating advanced treatments that target the relationship between the nervous and immune systems. Its leading treatment candidates address serious conditions including acute lung injury, epilepsy, dementia, and Alzheimer's disease, each at various stages of clinical testing. The company is also developing therapies for brain cancer and chronic wounds, with ongoing research partnerships to strengthen its work in infection-resistant wound care.
